Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darbepoetin alfa vs recombinant human erythropoietin in hemodialysis patients with renal anemia (ESA‑naïve)
CTR20130080Phase 3Completed
- Sponsor
- Kyowa Kirin
- Start
- Mar 2014
- Modality
- Erythropoietins → Hormones & Growth Factors → Recombinant Proteins and Enzymes, Interleukins → Cytokines & Interferons → Recombinant Proteins and Enzymes, Colony Stimulating Factors → Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of darbepoetin alfa in anaemia, sponsored by Kyowa Kirin. Started Mar 2014; status: completed.
02
Drugs
darbepoetin alfa
03
Conditions
anaemia
Beyond the preview
Go deeper on CTR20130080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130080.